These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21235478)
1. Foam preparations for the treatment of ulcerative colitis. Loew BJ; Siegel CA Curr Drug Deliv; 2012 Jul; 9(4):338-44. PubMed ID: 21235478 [TBL] [Abstract][Full Text] [Related]
2. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]
5. Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy. Brown J; Haines S; Wilding IR Aliment Pharmacol Ther; 1997 Aug; 11(4):685-91. PubMed ID: 9305476 [TBL] [Abstract][Full Text] [Related]
6. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560 [TBL] [Abstract][Full Text] [Related]
7. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
9. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Campieri M; Corbelli C; Gionchetti P; Brignola C; Belluzzi A; Di Febo G; Zagni P; Brunetti G; Miglioli M; Barbara L Dig Dis Sci; 1992 Dec; 37(12):1890-7. PubMed ID: 1473437 [TBL] [Abstract][Full Text] [Related]
10. Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis. Stobaugh DJ; Deepak P; Thorpe M; Hannon B; Ehrenpreis ED Inflamm Bowel Dis; 2013 Feb; 19(2):301-8. PubMed ID: 22644716 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis. Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V; Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738 [TBL] [Abstract][Full Text] [Related]
12. A practical guide to the management of distal ulcerative colitis. Ardizzone S; Bianchi Porro G Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342 [TBL] [Abstract][Full Text] [Related]
13. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial. Gionchetti P; Ardizzone S; Benvenuti ME; Bianchi Porro G; Biasco G; Cesari P; D'albasio G; De Franchis R; Monteleone G; Pallone F; Ranzi T; Trallori G; Valpiani D; Vecchi M; Campieri M Aliment Pharmacol Ther; 1999 Mar; 13(3):381-8. PubMed ID: 10102972 [TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054 [TBL] [Abstract][Full Text] [Related]
15. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960 [TBL] [Abstract][Full Text] [Related]
17. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848 [TBL] [Abstract][Full Text] [Related]
18. Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis. Gionchetti P; Venturi A; Rizzello F; Corbelli C; Fanti S; Ferretti M; Boschi S; Miglioli M; Campieri M Aliment Pharmacol Ther; 1997 Aug; 11(4):679-84. PubMed ID: 9305475 [TBL] [Abstract][Full Text] [Related]
19. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063 [TBL] [Abstract][Full Text] [Related]
20. [Acute pericarditis associated with oral or topical mesalazine therapy in patients with ulcerative colitis]. Calafat M; Mañosa M; Cabré E; Domènech E Gastroenterol Hepatol; 2014 Apr; 37(4):254-5. PubMed ID: 24333139 [No Abstract] [Full Text] [Related] [Next] [New Search]